Evidence map›Paper›PMID 26564042›Full record

ArticleGenome announcements2015

Whole-Genome Sequence of Mycobacterium bovis BCG-1 (Russia).

R Ludannyy, M Alvarez Figueroa, D Levi, M Markelov, V Dedkov, N Aleksandrova, G Shipulin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genome announcements, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

R LudannyyCentral Research Institute for Epidemiology of Federal Service on Consumers' Rights Protection and Human Well-Being Surveillance, Moscow, Russia ruslan_ludanny@hotmail.com.ORCID http://orcid.org/0000-0002-8094-855X
M Alvarez FigueroaCentral Research Institute for Epidemiology of Federal Service on Consumers' Rights Protection and Human Well-Being Surveillance, Moscow, Russia.
D LeviCenter for Expertise and Control of Immunobiological Preparation (CEC) of Scientific Center for Expertise of Medical Application Products, Ministry of Health, Moscow, Russia.
M MarkelovCentral Research Institute for Epidemiology of Federal Service on Consumers' Rights Protection and Human Well-Being Surveillance, Moscow, Russia.
V DedkovCentral Research Institute for Epidemiology of Federal Service on Consumers' Rights Protection and Human Well-Being Surveillance, Moscow, Russia.
N AleksandrovaCenter for Expertise and Control of Immunobiological Preparation (CEC) of Scientific Center for Expertise of Medical Application Products, Ministry of Health, Moscow, Russia.
G ShipulinCentral Research Institute for Epidemiology of Federal Service on Consumers' Rights Protection and Human Well-Being Surveillance, Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BCG vaccine (Mycobacterium bovis BCG-1 [Russia]) is the most important component of tuberculosis prophylaxis in Russia. This study represents the complete genome sequence and genetic characteristics of M. bovis BCG-1 (Russia), which has been used to manufacture BCG vaccine in Russia and in some other countries.

Identifiers

PMID26564042
PMCPMC4972778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.